[Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature]

Rev Esp Patol. 2022 Sep:55 Suppl 1:S64-S68. doi: 10.1016/j.patol.2020.02.004. Epub 2020 Apr 18.
[Article in Spanish]

Abstract

Syringocystadenoma papilliferum (SCAP), tubular adenoma (TA) and hydrocystoma (HC) are benign adnexal tumors. Recently it has been suggested that these lesions belong to the same morphological spectrum: Tubulopapillary cystic adenoma with apocrine differentiation (TPCAa). BRAF and K-Ras (KRAS) mutations have been described in SCAP and TA, but not in HC. Moreover, verrucous epithelial proliferations have been observed in TPCAa. We present a case of TPCAa with BRAF V600E mutation and BRAF VE1 immunohistochemical expression in the SCAP, AT, HC and verrucous hyperplasia components.

Keywords: Adenoma tubular; Hidrocistoma y BRAF; Hidrocystoma and BRAF; Siringocistadenoma papilífero; Syringocystadenoma papilliferum; Tubular adenoma.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adenoma* / genetics
  • Adenoma* / pathology
  • Gastrointestinal Neoplasms*
  • Humans
  • Mutation
  • Proto-Oncogene Proteins B-raf / genetics
  • Sweat Gland Neoplasms* / genetics
  • Sweat Gland Neoplasms* / pathology
  • Tubular Sweat Gland Adenomas* / genetics
  • Tubular Sweat Gland Adenomas* / pathology

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf